The efficacy of venlafaxine in treatment of depression in Parkinson`s disease
Objective: Depression is the most common psychiatric disorder appearing in Parkinson‘s Disease (PD) with an average prevalence rate almost 40-50 %. Selective serotonin and norepinephrine reuptake inhibitors (SNRIs) are currently used in the treatment of depression in patients with PD, but we have n...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Mesut Çetin
2021-02-01
|
| Serie: | Psychiatry and Clinical Psychopharmacology |
| Soggetti: | |
| Accesso online: | https://psychiatry-psychopharmacology.com/index.php/pub/article/view/690 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|